Weve all heard that stopping taking a GLP-1 medication for weight losssuch as semaglutide (marketed as Wegovy) and tirzepatide (sold as Zepbound)often leads to rapid weight gain, with people returning to baseline in as little as 18 months
And on Trustpilot, 49% of reviewers gave Willow just one star
Spurney, C
(2017) CHAC1 degradation of glutathione enhances cystine-starvation-induced necroptosis and ferroptosis in human triple negative breast cancer cells via the GCN2-eIF2-ATF4 pathway, Oncotarget , 8 , 114588-114602, doi: Lei, P., Bai, T., and Sun, Y
Meanwhile, this past April, the Trump administration announced that Medicare and Medicaid will not be covering obesity medications, including GLP-1s
This increase could have resulted in the increase in food and water intakes of rats